Gain insight into the latest interdisciplinary research on HIV prevention and early infection, and key questions that still need to be answered for clinical advances in HIV prevention and ultimate elimination to be made.
Session Chair: Prof Thumbi Ndung'u
AHRI Deputy Director, Science; SANTHE Programme Director; Max Planck Institute for Infection Biology Group Leader; South African Research Chair in Systems Biology of HIV/AIDS.
Engaging young people living in communities most affected by HIV on early infection – Nonhlanhla Okesola, AHRI Multi-level HIV Prevention
2 000 young women in South Africa become HIV-infected every week. What’s going on? – Dr Krista L Dong, FRESH Clinical Director/Co-PI; Ragon Institute of MGH, Harvard & MIT
Strategies to prevent HIV-infection in young at-risk females in the
FRESH Cohort: are we winning or losing? - Amber Moodley, FRESH Programme Manager
Quantification and characterisation of the HIV reservoir in the FRESH Cohort – Dr Kavidha Reddy, AHRI Postdoctoral Research Fellow/SANTHE Researcher & Supervisor
Neutralisation of HIV-1 subtype C transmitted/ founder viruses by broadly neutralising monoclonal antibodies – Dr Bongiwe Ndlovu, HPP Faculty Member
Panel & audience discussion
Dr Al Leslie – AHRI Faculty Member/SANTHE Senior Researcher & Supervisor Dr Oluwafemi Adeagbo – AHRI Senior Social Scientist
Dr Kamini Gounder – AHRI Research Associate/SANTHE Researcher, Supervisor & Collaborative Grant Awardee
Dr Zaza Ndhlovu – AHRI Faculty Member/SANTHE Senior Researcher, Supervisor & Collaborative Grant Awardee